Cost Effectiveness of Medical versus Surgical Treatment in Patients with Severe or Refractory Gastroesophageal Reflux Disease in The Netherlands

References

• Savary M, Miller G. The esophagus-handbook and atlas of endoscopy. Verlag Gassmann AG, Solothum Switzerland 1978
   Google Scholar
• Sölvell L. The clinical safety of omeprazole. Scand J Gastroenterol 1989; 24: 106–10, Suppl 166
   Web of Science ®Google Scholar
• Siewert JR, Feussner H. Surgical considerations for antireflux therapy. Scand J Gastroenterol 1989; 24: 50–9, Suppl 168
   Google Scholar
• Riet G ter, Bouter LM. Meta analysis of therapeutic experiments I & II: proposal for a protocol (in Dutch). T Soc Gezondheidsz 1990; 68: 186–9
   Google Scholar
• Steering Committee Future Scenarios in Health Care. Calculation of costs in health care research: guidelines for practical use (in Dutch). Jan van Arkel, Utrecht 1993
   Google Scholar
• Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, MacCarthy JH. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–12
   PubMed Web of Science ®Google Scholar
• Zeitoun P, Rampal P, Barbier P, Isal J-P, Eriksson S, Carlsson R. Omeprazole (20 mg o.m.) versus ranitidine (150 mg b.i.d.) in reflux esophagitis. Results of a double-blind randomized trial. Gastroenterol Clin Biol 1989; 13: 457–62
   PubMedGoogle Scholar
• Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results from a double-blind randomized Scandinavian multicentre study. Scand J Gastroenterol 1988; 23: 625–32
   PubMed Web of Science ®Google Scholar
• Havelund T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA, Jensen KB. Omeprazole and ranitidine in treatment of reflux esophagitis: double-blind comparative trial. Br Med J 1988; 296: 89–92
   PubMed Web of Science ®Google Scholar
• Vantrappen G, Rutgeers L, Schurmans P, Coenegrachts J-L. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 1988; 33: 523–9
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol EC, Jansen JM, Festen HP, Meuwissen SG, Lamers CB. Double blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux esophagitis. Lancet 1987; 1: 394–51
   Google Scholar
• Howard JM, Frei JV, Flowers M, Bondy DC, Tilbe K, Reynolds RT. Omeprazole heals esophagitis but does not improve abnormal esophageal motility in reflux esophagitis. Gastroenterology 1990; A61, Suppl 98
   Google Scholar
• Dammann HG, Blum AL, Lux G, Rehner M, Riecken EO, Schiessel R. Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicentre study. Dtsch Med Wochenschr 1986; 111: 123–8
   PubMedGoogle Scholar
• Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P, Ekstrom P. Lansoprazole vs. omeprazole in short-term treatment of reflux esophagitis. Results of a Scandinavian multicentre trial. Gastroenterology 1992; A80, Suppl 102
   Google Scholar
• Lauritsen K, Laursen LS, Bondesen S, Hansen J, Sanchez G, Sebelin E. Omeprazole 20 mg or 40 mg daily for the treatment of gastroesophageal reflux disease? A double-blind comparative study. Gastroenterology 1992; A110, Suppl 102
   Google Scholar
• Sontag SJ, Hirschowitz BI, Holt S, Robison MG, Behar J, Berenson MM. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. multicentre study. Gastroenterology 1992; 102: 109–18
   PubMed Web of Science ®Google Scholar
• Dehn TC, Shepherd HA, Colin-Jones D, Kettlewell MG, Carroll NJ. Double blind comparison of omeprazole (40 mg 1x) vs cimetidine (400 mg 4x) in the treatment of symptomatic erosive reflux oesophagitis assessed endoscopically histologically and by 24 h pH-monitoring. Gut 1990; 31: 509–13
   PubMed Web of Science ®Google Scholar
• Ruth M, Enbom H, Lundell H, Lönroth H, Sandberg N, Sandmark S. The effect of omeprazole or ranitidine treatment on 24 hour oesophageal acidity in patients with reflux esophagitis. Scand J Gastroenterol 1988; 23: 1141–6
   PubMed Web of Science ®Google Scholar
• Bate CM, Keeling PWN, O'Morain C, Wilkinson SP, Foster DN, Mountford RA. Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. Gut 1990; 31: 968–72
   PubMed Web of Science ®Google Scholar
• Toledo-Pimentel V, Ros E, Bordas JM, Grande L, Lacima G. Reflux esophagitis refractory to high-dose histamine H2-antagonists. Healing with omeprazole. Gastroenterology 1992; A179, Suppl 102
   Google Scholar
• Marciano D'Amore DA, Paterson WG, Da Costa LR, Beck IT. Omeprazole in H2-receptor antagonist-resistant reflux esophagitis. J Clin Gastroenterol 1990; 12: 616–20
   Google Scholar
• Bardhan KD, Daly MJ, Singh S, Morris P, Thompson M, Hinchliffe RFC. Refractory esophagitis: results of maintenance treatment with high-dose H2-receptor antagonists (H2RA) or omeprazole (OM). Gastroenterology 1990; A18, Suppl 98
   Google Scholar
• Lind T, Cederberg C, Idström H, Lönroth H, Olbe L, Lundell L. 24-Hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis. Scand J Gastroenterol 1991; 26: 620–6
   PubMed Web of Science ®Google Scholar
• Koop H, Hotz J, Pommer G, Klein M, Arnold R. Prospective evaluation of omeprazole treatment in reflux esophagitis refractory to H2 receptor antagonists. Aliment Pharmacol Ther 1990; 4: 593–9
   PubMed Web of Science ®Google Scholar
• Lundell L, Backman L, Ekstrom P, Enander LH, Fausa O, Lind T. Omeprazole or high-dose ranitidine in the treatment of patients with reflux esophagitis not responding to ‘standard doses’ of H2-receptor antagonists. Aliment Pharmacol Ther 1990; 4: 145–55
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol EC, Jansen JM, Festen HP, Lamers CB, Nelis F, Snel P. Efficacy and safety of omeprazole in the short- and long-term treatment of reflux esophagitis resistant to H2-receptor antagonists. Recent advances in the diagnosis and management of gastro-oesophageal reflux disease. VU University Press, Amsterdam 1990
   Google Scholar
• Brunner G, Creutzfeldt W, Harke U, Lamberts R. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 1988; 39: 80–90
   PubMed Web of Science ®Google Scholar
• Sontag S, Hendrix T, Hirschowitz B, Roufail W, Fong C, Lipschutz K. Omeprazole for esophagitis and ulcers refractory to H2-blockers. Gastroenterology 1988; A436, Suppl 94
   Google Scholar
• Ching CK, Shaheen MZ, Holmes GKT. Is omeprazole more effective in the treatment of resistant reflux esophagitis and associated peptic stricture. Gastroenterology 1990; A30, Suppl 98
   Google Scholar
• Bardhan KD, Daly MJ, Singh S, Morris P, Thompson M, Hinchliffe RFC. Refractory esophagitis: results of maintenance treatment with high-dose H2-receptor antagonists (H2RA) or omeprazole (OM). Gastroenterology 1990; A18, Suppl 98
   Google Scholar
• Hill ADK, Donoghue DP. Omeprazole in refractory reflux esophagitis. Gullet 1991; 1: 81–3
   Google Scholar
• Klinkenberg-Knol EC, Jansen JMBJ, Lamers CBHW. Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor antagonist resistant reflux oesophagitis: effects on symptoms, endoscopy, serum gastrin levels and gastric acid output. Scand J Gastroenterol 1990; 25: 1144–50
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol EC. Recent advances in the diagnosis and management of gastro-oesophageal reflux disease: the role of omeprazole in clinical practice. VU University Press, Amsterdam 1990
   Google Scholar
• Lundell L, Backman L, Ekström P, Enander L-K, Falkmer S, Fausa O. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 1991; 26: 248–56
   PubMed Web of Science ®Google Scholar
• Koop H, Arnold R. Long-term maintenance treatment of reflux esophagitis with omeprazole: prospective study in patients with H2-blocker-resistant esophagitis. Dig Dis Sci 1991; 36: 552–7
   PubMedGoogle Scholar
• Donahue PE, Samelson S, Nyhus LM, Bombeck CT. The floppy Nissen fundoplication. Arch Surg 1985; 120: 663–7
   PubMedGoogle Scholar
• Johansson KE, Tibbling L. Maintenance treatment with ranitidine compared with fundoplication in gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 779–88
   PubMed Web of Science ®Google Scholar
• Glise H. Healing, relapse rates and prophylaxis of reflux esophagitis. Scand J Gastroenterol 1989; 24: 57–64, Suppl 156
   PubMed Web of Science ®Google Scholar
• Johnsson H, Joelson B, Gudmundsson K, Floren CH, Walther B. Effects of fundoplication on the antireflux mechanism. Br J Surg 1987; 74: 1111–4
   PubMedGoogle Scholar
• Ortiz Escandell A, Martinez de Haro LF, Parrilla Paricio P, Aguayo Albasini JL, Garcia Marcilla JA, Morales Cuenca G. Surgery improves defective oesophageal peristalsis in patients with gastro-oesophageal reflux. Br J Surg 1991; 78: 1095–7
   PubMedGoogle Scholar
• Martinez de Haro LF, Ortiz A, Parrilla P, Garcia Marcilla JA, Aguayo JL, Morales G. Long-term results of Nissen fundoplication in reflux esophagitis without strictures. Clinical, endoscopic, and pH-metric evaluation. Dig Dis Sci 1992; 37: 523–7
   Google Scholar
• Walker SJ, Holt S, Sanderson CJ, Stoddard CJ. Comparison of Nissen total and Lind partial transabdominal fundoplication in the treatment of gastro-oesophageal reflux. Br J Surg 1992; 79: 410–4
   Google Scholar
• DeMeester TR, Bonavina L, Albertucci M. Nissen fundoplication for gastro-esophageal reflux disease: evaluation of primary repair in 100 consecutive patients. Ann Surg 1986; 204: 9–20
   PubMed Web of Science ®Google Scholar
• Stipa S, Fegiz G, Iascone G, Paolini A, Moraldi A, De Marchi C. Belsey and Nissen operations for gastroesophageal reflux. Ann Surg 1989; 210: 583–9
   PubMed Web of Science ®Google Scholar
• Thor KJB, Silander T. A long-term randomized prospective trial of the Nissen procedure versus a modified Toupet technique. Ann Surg 1989; 210: 719–24
   PubMed Web of Science ®Google Scholar
• Little AG, Naunheim KS, Ferguson MK, Skinner DB. Surgical management of esophageal strictures. Ann Thorac Surg 1988; 45: 144–7
   Google Scholar
• Mughal MM, Bancewicz J, Marples M. Oesophageal manometry and pH recording does not predict the bad results of Nissen fundoplication. Br J Surg 1990; 77: 43–5
   PubMed Web of Science ®Google Scholar
• O'Hanrahan T, Marples M, Bancewicz J. Recurrent reflux and wrap disruption after Nissen fundoplication: detection incidence and timing. Br J Surg 1990; 77: 545–7
   PubMed Web of Science ®Google Scholar
• Segol PH, Hay JM, Pottier D. Traitement chirurgical du reflux gastro-oesophagien: quelle intervention choisir: Nissen Toupet ou Lortat-Jacob. Gastroenterol Clin Biol 1989; 13: 873–879
   PubMedGoogle Scholar
• Saubier EC, Gouillat C, Teboul F. Traitement du reflux gastro-oesophagien par fundoplicature complete de Nissen. Resultats de 112 observations. Chirurgie 1986; 112: 123–31
   Google Scholar
• Macintyre IMC, Goulbourne IA. Long-term results after Nissen fundoplication: a 5–15-year review. J R Coll Surg Edinb 1990; 35: 159–62
   PubMedGoogle Scholar
• O'Rourke IC. Fundoplicátion for gastro-esophageal reflux. Aust N Z J Surg 1985; 55: 347–54
   Google Scholar
• Stuart RC, Dawson K, Keeling P, Byrne PJ, Hennessy TP. A prospective randomized trial of Angelchik prosthesis versus Nissen fundoplication. Br J Surg 1989; 76: 86–9
   Google Scholar
• Feussner H, Petri A, Walker S, Bollschweiler E, Siewert JR. The modified AFP score: an attempt to make the results of antireflux surgery comparable. Br J Surg 1991; 78: 942–6
   Google Scholar
• Johansson KE, Tibbling L. Esophageal body motor disturbances in gastroesophageal reflux and the effect of fundoplication. Scand J Gastroenterol 1988; 23: 82–8, Suppl 155
   Web of Science ®Google Scholar
• Shirazi SS, Schulze K, Soper RT. Long-term follow-up for treatment of complicated chronic reflux esophagitis. Arch Surg 1987; 122: 548–51
   PubMedGoogle Scholar
• Negre JB, Markkula HT, Keyrilainen O, Matikainen M. Nissen fundoplication: results at a ten year follow up. Am J Surg 1983; 146: 635–8
   PubMed Web of Science ®Google Scholar
• Breumelhof R, Smout AJPM, Schyns MWRJ, Bronzwaer PW, Akkermans LM, Jansen A. Prospective evaluation of the effects of Nissen fundoplication on gastroesophageal reflux. Surg Gynecol Obstet 1990; 171: 115–9
   PubMedGoogle Scholar
• Dallemagne B, Weerts JM, Jehaes C, Markiewicz S, Lombard R. Techniques and results of endoscopic fundoplication. Endosc Surg Allied Technol 1993; 1: 72–6
   Google Scholar
• Bate CM. Cost effectiveness of omeprazole in the treatment of reflux oesophagitis. Br J Med Econom 1991; 1: 53–61
   Google Scholar
• Barradell LB, McTavish D. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis. Pharmacoeconomics 1993; 3: 482–510
   PubMedGoogle Scholar
• Chapter 4. Health economics in the management of acid-related diseases. Scand J Gastroenterol 1994; 29: 87–104, Suppl 201
   PubMedGoogle Scholar